Company: NeuGen Fund (formerly known as ISCOS ReGen Fund)


Company Description

NeuGen Fund (formerly known as ISCOS ReGen Fund) is a fund backed by the ISCOS Group and registered with the Authority of Singapore. It is dedicated to advancing the development and commercialization of advanced regenerative technologies and medicines. NeuGen Fund seeks to invest in companies and projects that bring innovative and practical solutions to address the unmet needs in regenerative medicine, biotechnology and medical technology. The Fund invests in early-stage pre-clinical and clinical drug development pipelines, advanced medical technologies, next-generation tissue engineering and bio-manufacturing processes, and breakthrough regenerative and preventive products. The fund also provides advice and support to its portfolio companies from business and industry, regulatory, and clinical perspectives.

More vacancies in NeuGen Fund (formerly known as ISCOS ReGen Fund)